ABBV 📈 AbbVie - Overview

AbbVie Inc, a multinational pharmaceutical company, operates on a global scale, focusing on the discovery, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company's portfolio includes notable medications such as Humira, which is used to treat autoimmune diseases, intestinal Behçet's disease, and pyoderma gangrenosum through injection. Additionally, AbbVie offers Skyrizi for the treatment of moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease, while Rinvoq is used to treat various conditions including rheumatoid and psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis.

AbbVie's product lineup also encompasses treatments for blood cancers, including Imbruvica, which is designed for adult patients, and Epkinly, used to treat lymphoma. The company also offers Elahere for cancer treatment and Venclexta/Venclyxto for blood cancers. Furthermore, AbbVie provides a variety of aesthetic products such as facial injectables, plastics and regenerative medicine, body contouring, and skincare products, in addition to Botox therapeutic. The company's neurological disorder treatments include Vraylar for depressive disorder, Duopa and Duodopa for advanced Parkinson's disease, Ubrelvy for the acute treatment of migraine in adults, and Qulipta for episodic and chronic migraine.

In the realm of eye care, AbbVie offers Ozurdex for the treatment of eye diseases, Lumigan/Ganfort and Alphagan/Combigan to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension, and Restasis to increase tear production. The company also provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection, Creon, a pancreatic enzyme therapy, Lupron to treat advanced prostate cancer, endometriosis, and central precocious puberty, and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. Synthroid is another key product, used to treat hypothyroidism.

AbbVie has established collaborations with several notable companies, including Calico Life Sciences LLC, REGENXBIO Inc, Janssen Biotech, Inc, Evolveimmune Therapeutics, Inc, Genentech, Inc, and Tentarix Biotherapeutics, LP. Incorporated in 2012, the company is headquartered in North Chicago, Illinois, and its common stock is listed under the ISIN US00287Y1091, classified as a biotechnology company within the GICS Sub Industry. For more information, the company's website can be accessed at https://www.abbvie.com.